IRIS
RENDA, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.601
EU - Europa 3.094
AS - Asia 1.755
Continente sconosciuto - Info sul continente non disponibili 11
AF - Africa 5
SA - Sud America 3
OC - Oceania 1
Totale 8.470
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.591
IE - Irlanda 685
CN - Cina 657
UA - Ucraina 622
SG - Singapore 509
TR - Turchia 470
SE - Svezia 468
IT - Italia 418
GB - Regno Unito 251
DE - Germania 187
FR - Francia 158
FI - Finlandia 126
RU - Federazione Russa 109
IN - India 56
IR - Iran 22
BE - Belgio 21
PL - Polonia 18
VN - Vietnam 16
EU - Europa 10
CA - Canada 9
HK - Hong Kong 9
CZ - Repubblica Ceca 8
EG - Egitto 5
IL - Israele 4
NL - Olanda 4
RO - Romania 4
AT - Austria 3
BR - Brasile 3
DK - Danimarca 3
JP - Giappone 3
AE - Emirati Arabi Uniti 2
HU - Ungheria 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
CY - Cipro 1
GE - Georgia 1
GR - Grecia 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LU - Lussemburgo 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
RS - Serbia 1
Totale 8.470
Salva come PNG Salva come JPEG
Città #
Jacksonville 756
Dublin 666
Chandler 649
Singapore 445
Princeton 337
Izmir 224
Nanjing 201
Southend 196
Ashburn 147
Altamura 118
Dearborn 117
Cambridge 116
Santa Clara 113
Wilmington 112
Beijing 104
Nanchang 87
Ann Arbor 79
Chieti 60
Boardman 39
Hebei 39
Los Angeles 38
Shenyang 38
Woodbridge 38
Kunming 35
New York 29
Tianjin 25
Washington 24
Augusta 23
Jiaxing 23
San Mateo 23
Grevenbroich 22
Norwalk 22
Brussels 21
Changsha 20
Leawood 20
Ardabil 17
Pescara 17
Dong Ket 15
Falls Church 15
Helsinki 15
Kraków 15
Hangzhou 14
Houston 11
Hefei 10
Munich 9
Brno 8
Hong Kong 8
Lanzhou 8
Toronto 8
Guangzhou 7
Rome 7
Seattle 7
Taizhou 7
Jinan 6
Milan 6
Monmouth Junction 6
Teramo 6
Bologna 5
Cairo 5
Düsseldorf 5
Messina 5
Amsterdam 4
Auburn Hills 4
Beersheba 4
Brindisi 4
Fort Worth 4
Fuzhou 4
L'aquila 4
Moscow 4
Mumbai 4
Ningbo 4
Redwood City 4
Tappahannock 4
Bangalore 3
Campodipietra 3
Changchun 3
Chicago 3
Florence 3
Intra 3
Kocaeli 3
Lappeenranta 3
Mountain View 3
Penne 3
Pune 3
San Francisco 3
Solofra 3
Spoltore 3
Zhengzhou 3
Ardea 2
Bari 2
Budapest 2
Caiatia 2
Chongqing 2
Copenhagen 2
Cormeilles-en-Parisis 2
Dubai 2
Giulianova 2
Limerick 2
London 2
Orange 2
Totale 5.365
Salva come PNG Salva come JPEG
Nome #
Increased left atrial size in obese children and its association with insulin resistance: a pilot study 123
Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial 111
Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents 110
Response to "Pharmacodynamic Interaction Between Aspirin and Ibuprofen: A Plausible Mechanism of Aspirin Resistance" 106
Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery 99
Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy 96
Failure in evoking the trigeminal cardiac reflex by mandibular stretching in healthy volunteers 93
Intracardiac thrombi during warfarin anticoagulation - A case report and a brief literature review 90
Rapid decline of collateral circulation increases susceptibility to myocardial ischemia: the trade-off of successful percutaneous recanalization of chronic total occlusions 88
Aneurisma coronarico: scoperta generalmente casuale, prognosi sempre severa? 86
La gestione del rischio tromboembolico nei pazienti con fibrillazione atriale in Italia: Dati al follow-up del Registro Europeo PREFER in AF 85
Genetic determinants of blood pressure responses to caffeine drinking 84
Direct Oral Anticoagulants Halve Thromboembolic Events After Cardioversion of AF Compared With Warfarin 83
Effects of endurance, resistance and neuro-muscular electrical stimulation trainings to the anthropometric and functional mobility domains in elderly 83
Genetic determinants of cognitive responses to caffeine drinking identified from a double-blind, randomized, controlled trial 82
Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects 81
Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: recommendations to minimize the functional consequences 81
Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease 80
Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease 79
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 78
Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies 77
INCREASED THROMBOXANE PRODUCTION BY MONOCYTE PROSTAGLANDIN ENDOPEROXIDE SYNTHASE-2 IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION. 76
Sex Implications in the Response to Anticoagulant Therapy in Atrial Fibrillation ∗ 76
Facilitated PCI: Rationale, current evidence, open questions and future directions 75
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease 75
Increased thromboxane production by monocyte prostaglandin endoperoxide synthase-2 in patients with acute myocardial infarction (pubbl. su Suppl. Circulation) 74
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors 74
The Role of Multimodality Cardiovascular Imaging in Peripartum Cardiomyopathy 73
Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects 72
The left atrial appendage: from embryology to prevention of thromboembolism 72
Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries 70
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial 70
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper 69
Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF 69
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 69
EFFECTS OF NIMESULIDE ON CONSTITUTIVE AND INDUCIBLE PROSTANOID BIOSYNTHESIS IN MAN. 68
Incomplete suppression of platelet COX-1 activity associated with aspirin-resistant thromboxane biosynthesis in acute coronary syndromes 68
Edoxaban for the Prevention of Thromboembolism in Patients with Atrial Fibrillation and Bioprosthetic Valves 68
Coffee: Health Effects 68
New anticoagulants for atrial fibrillation 67
Celecoxib, ibuprofen and the antiplatelet effect of aspirin in patients with osteoarthritis and chronic stable angina 67
Management of thromboembolic risk in patients with atrial fibrillation in Italy: baseline data from the PREFER in AF European Registry 66
Non-vitamin K Antagonist Oral Anticoagulants for Cardioversion in Atrial Fibrillation - An Updated Meta-analysis 66
Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W 65
An early decline of collateral circulation parallels myocardial ischaemia during percutaneous coronary intervention: a drawback of recanalization of chronic coronary occlusions? 65
AF: current and forthcoming antithrombotic therapies 65
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 64
Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy 64
Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation 64
Atrial and left atrial appendage thrombosis in patients with atrial fibrillation: from pathophysiology to treatment 64
Dose- Dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects. 63
Cardiovascular and psychological reactivity after caffeine consumption 63
Cardiovascular effects of caffeine during cognitive tasks 63
Prognostic significance of noncardiac syncope in the general population: A systematic review and meta-analysis 63
The legacy of ISCHEMIA 63
Antithrombotic therapy in atrial fibrillation: state of the art and perspectives. 62
Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects 61
Blood pressure modifications after caffeine intake during cognitive tasks 60
Systolic and diastolic dysfunction occurs in newly diagnosed patients with hypertension and high systolic blood pressure variability 60
MECHANISMS OF ISOPROSTANE BIOSYNTHESIS IN HUMANS 59
Measurements of thromboxane production and their clinical significance in coronary heart disease 59
A comparison between unfractioned heparin and a low molecular weight heparin in cardiac surgery 59
Platelet Indices and Risk of Death and Cardiovascular Events: Results from a Large Population-Based Cohort Study 59
Echocardiographic screening for the anomalous aortic origin of coronary arteries 58
Nutrigenetics of blood pressure responses to coffee drinking 57
Systolic and diastolic dysfunction occurs in newly diagnosed patients with hypertension and high systolic blood pressure variability 57
Antithrombotic management 57
The AVERROES Trial – Clinical Implications 57
Enhanced thromboxane biosynthesis in patients with colorectal and lung cancer 57
Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban 56
CHA2DS2VASc score and adverse outcomes in middle-aged individuals without atrial fibrillation 56
Risk of Atrial Fibrillation in Masked and White Coat Uncontrolled Hypertension 56
EFFECTS OF NIMESULIDE ON CONSTITUTIVE AND INDUCIBLE PROSTANOID BIOSYNTHESIS IN HUMAN BEINGS 54
Autonomic nervous system dysfunction in obese children 54
Surgical bleeding after preoperative unfractionated heparin and low molecular weight heparin at coronary bypass surgery 54
Parmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects 54
Antithrombotic prophylaxis in the elderly with atrial fibrillation 54
Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe. 54
Late coronary thrombosis after drug-eluting stent: stent vs patient-driven prescription of aspirin-clopidogrel combination 54
Effect of fibrinogen concentration on the antiplatelet effect of tirofiban 54
DIFFERENTIAL INHIBITION OF HUMAN PROSTAGLANDIN ENDOPEROXIDE SYNTHASE-1 AND -2 BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS 53
P6223Relationship between platelet indices and future cardiovascular events: results from a population-based cohort study 53
ENHANCED CORTISOL SECRETION DOES NOT CONTROL ASPIRIN-INSENSITIVE THROMBOXANE BIOSYNTHESIS IN PATIENTS WITH ACUTE CORONARY SYNDROMES. 52
Systolic blood pressure variability by non-invasive monitoring predicts intima-media thickness independent of absolute blood pressure levels 52
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 52
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation 52
Prognostic value of non-resistant and resistant masked uncontrolled hypertension detected by ambulatory blood pressure monitoring 52
ENHANCED CORTISOL SECRETION DOES NOT CONTROL ASPIRIN-INSENSITIVE THROMBOXANE BIOSYNTHESIS IN PATIENTS WITH ACUTE CORONARY SYNDROMES 51
Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension 51
A comparison between unfractionated heparin and a low molecular weight heparin in cardiac surgery 51
Aspirin Resistance 51
Systolic blood pressure response to coffee is modulated by alpha2B adrenergic receptor I/D polymorphism 50
Ruolo del fibrinogeno e della conta piastrinica sull’inibizione dell’aggregazione piastrinica da parte dei farmaci anti-glicoproteina IIbIIIa 50
Triple antithrombotic therapy with aspirin, clopidogrel and warfarin – a persisting dilemma 50
Terapia dell’infarto miocardico e delle sindromi coronariche 49
Inhibitory effect of coffee on platelet aggregation 49
Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis 49
HETEROGENEITY IN THE SUPPRESSION OF PLATELET CYCLOOXYGENASE-1 ACTIVITY BY ASPIRIN IN CARDIOVASCULAR DESEASE. 48
Images in cardiovascular medicine. Membrane-type subaortic stenosis in the adult. 48
Circadianicity of hemostatic function and coronary vasomotion 48
Totale 6.646
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.278
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.278
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020948 0 0 13 47 140 79 193 149 62 98 161 6
2020/2021947 130 4 144 25 112 170 22 22 36 102 142 38
2021/2022691 12 5 5 126 82 8 17 62 64 18 71 221
2022/20232.004 182 282 117 193 181 391 139 137 268 23 51 40
2023/2024961 75 17 57 11 51 299 221 46 11 29 30 114
2024/2025913 168 442 303 0 0 0 0 0 0 0 0 0
Totale 9.077